Abstract
Long noncoding RNAs (lncRNAs) were reported to play important roles in the pathogenesis of ischemic stroke (IS). Our study aimed to investigate the role of lncRNA SERPINB9P1 expression in ischemic stroke and the association between SERPINB9P1 polymorphisms and IS risk, as well as examine the correlation of SERPINB9P1 expression and variants with clinical parameters of IS. The SERPINB9P1 levels in human participants and oxygen–glucose deprivation (OGD)–treated human A172 cells were measured by qRT-PCR. The SERPINB9P1 polymorphisms (rs375556 and rs318429) were genotyped by the MassARRAY platform. We found that the SERPINB9P1 expression was significantly downregulated in patients with IS compared with that in healthy controls. On the 14th day in the hospital, the SERPINB9P1 level in patients with moderate and severe stroke was significantly downregulated compared with the normal group. After stratification by gender, the rs375556 polymorphism was significantly associated with susceptibility to female IS in the recessive model, and the significant association remained after adjusting for age. After adjusting for gender and age, rs318429 was significantly associated with FPG and D-D levels, and rs375556 was significantly associated with INR and PTA levels in IS cases. Besides, the lncRNA SERPINB9P1 expressed downregulated in OGD/reoxygenation-treated human A172 cells. In conclusion, the lncRNA SERPINB9P1 may protect against cerebral ischemia–reperfusion injury and neurological impairment after IS. The SERPINB9P1 rs375556 polymorphism was associated with susceptibility to female IS, and SERPINB9P1 polymorphisms may influence the metabolism of blood glucose and regulation of coagulation function in patients with IS.
Similar content being viewed by others
References
Akhter MS, Biswas A, Abdullah SM, Behari M, Saxena R (2017) The role of PAI-1 4G/5G promoter polymorphism and its levels in the development of ischemic stroke in young Indian population. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 23:1071–1076
Baek JY, Yeo HY, Chang HJ, Kim KH, Kim SY, Park JW, Park SC, Choi HS, Kim DY, Oh JH (2014) Serpin B5 is a CEA-interacting biomarker for colorectal cancer. Int J Cancer 134:1595–1604
Buchthal B, Weiss U, Bading H (2018) Post-injury nose-to-brain delivery of activin A and serpinB2 reduces brain damage in a mouse stroke model. Molecular therapy: the journal of the American Society of Gene Therapy 26:2357–2365
Cabezas-Llobet N, Camprubi S, Garcia B, Alberch J, Xifro X (2018) Human alpha 1-antitrypsin protects neurons and glial cells against oxygen and glucose deprivation through inhibition of interleukins expression. Biochim Biophys Acta 1862:1852–1861
Campos MA, Lascano J (2014) alpha1 Antitrypsin deficiency: current best practice in testing and augmentation therapy. Ther Adv Respir Dis 8:150–161
Cheng H, Sun M, Wang ZL, Wu Q, Yao J, Ren G, Sun XL (2020) LncRNA RMST-mediated miR-107 transcription promotes OGD-induced neuronal apoptosis via interacting with hnRNPK. Neurochemistry international 133:104644.
Cheng X, Xu J, Gu M, Wang M, Sun B, Li Z, Ni G, Wang G, Weng Z, Shi Y, Zhang Z, Liu X (2018) Genetic variants in ALDH2 predict risk of ischemic stroke in a Chinese population. Gene 678:49–54
Choi SW, Kim BB, Choi DH, Park G, Shin BC, Song H, Kim D, Kim DM (2017) Stroke or left atrial thrombus prediction using antithrombin III and mean platelet volume in patients with nonvalvular atrial fibrillation. Clin Cardiol 40:1013–1019
Cucchiara B, George DK, Kasner SE, Knutsson M, Denison H, Ladenvall P, Amarenco P, Johnston SC (2019) Disability after minor stroke and TIA: a secondary analysis of the SOCRATES trial. Neurology 93:e708–e716
Deming Y, Dumitrescu L, Barnes LL, Thambisetty M, Kunkle B, Gifford KA, Bush WS, Chibnik LB, Mukherjee S, De Jager PL, Kukull W, Huentelman M, Crane PK, Resnick SM, Keene CD, Montine TJ, Schellenberg GD, Haines JL, Zetterberg H, Blennow K, Larson EB, Johnson SC, Albert M, Moghekar A, Del Aguila JL, Fernandez MV, Budde J, Hassenstab J, Fagan AM, Riemenschneider M, Petersen RC, Minthon L, Chao MJ, Van Deerlin VM, Lee VM, Shaw LM, Trojanowski JQ, Peskind ER, Li G, Davis LK, Sealock JM, Cox NJ, Alzheimer’s Disease Neuroimaging I, Alzheimer Disease Genetics C, Goate AM, Bennett DA, Schneider JA, Jefferson AL, Cruchaga C, Hohman TJ, (2018) Sex-specific genetic predictors of Alzheimer’s disease biomarkers. Acta Neuropathol 136:857–872
Ferreira LE, Secolin R, Lopes-Cendes I, Cabral NL, Franca PHC (2019) Association and interaction of genetic variants with occurrence of ischemic stroke among Brazilian patients. Gene 695:84–91
Flores AE, Pascotini ET, Kegler A, Gabbi P, Bochi GV, Barbisan F, Duarte T, Prado ALC, Duarte M, da Cruz IBM, Moresco RN, Santos ARS, Bresciani G, Royes LFF, Fighera MR (2017) ALA16VAL-MnSOD gene polymorphism and stroke: association with dyslipidemia and glucose levels. Gene 627:57–62
Flossmann E, Schulz UG, Rothwell PM (2004) Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 35:212–227
Gao N, Tang H, Gao L, Tu G, Luo H, Xia Y (2020) CYP3A4 and CYP11A1 variants are risk factors for ischemic stroke: a case control study. BMC Neurol 20:77
Ge Y (2020) The clinical value of serum cystatin C and coagulation function test in patients with acute cerebral infarction. Electronic Journal of General Stomatology 7:174–175
Ghaedi H, Zare A, Omrani MD, Doustimotlagh AH, Meshkani R, Alipoor S, Alipoor B (2018) Genetic variants in long noncoding RNA H19 and MEG3 confer risk of type 2 diabetes in an Iranian population. Gene 675:265–271
Gu L, Huang J, Li J, Huang S, Li M, Gong L, Li T, Su L (2018) Association of CALM1 rs3179089 Polymorphism with ischemic stroke in Chinese Han population. NeuroMol Med 20:271–279
Heit C, Jackson BC, McAndrews M, Wright MW, Thompson DC, Silverman GA, Nebert DW, Vasiliou V (2013) Update of the human and mouse SERPIN gene superfamily. Hum Genomics 7:22
Hu X, Zan X, Xie Z, Li Y, Lin S, Li H, You C (2017) Association between plasminogen activator inhibitor-1 genetic polymorphisms and stroke susceptibility. Mol Neurobiol 54:328–341
Huang J, Yang J, Li J, Chen Z, Guo X, Huang S, Gu L, Su L (2019) Association of long noncoding RNA H19 polymorphisms with the susceptibility and clinical features of ischemic stroke in southern Chinese Han population. Metab Brain Dis 34:1011–1021
Hurley MJ, Durrenberger PF, Gentleman SM, Walls AF, Dexter DT (2015) Altered expression of brain proteinase-activated receptor-2, trypsin-2 and serpin proteinase inhibitors in Parkinson’s disease. Journal of molecular neuroscience: MN 57:48–62
Hurth H, Birkenhauer U, Steiner J, Schlak D, Hennersdorf F, Ebner FH (2020) Delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage - serum D-dimer and C-reactive protein as early markers. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 29:104558.
Ishii N, Ozaki K, Sato H, Mizuno H, Susumu S, Takahashi A, Miyamoto Y, Ikegawa S, Kamatani N, Hori M, Satoshi S, Nakamura Y, Tanaka T (2006) Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet 51:1087–1099
Kim JW, Lee SH, Ko HM, Kwon KJ, Cho KS, Choi CS, Park JH, Kim HY, Lee J, Han SH, Ignarro LJ, Cheong JH, Kim WK, Shin CY (2011) Biphasic regulation of tissue plasminogen activator activity in ischemic rat brain and in cultured neural cells: essential role of astrocyte-derived plasminogen activator inhibitor-1. Neurochem Int 58:423–433
Krishnamurthi RV, Ikeda T, Feigin VL (2020) Global, regional and country-specific burden of ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage: a systematic analysis of the global burden of disease study 2017. Neuroepidemiology 54:171–179
Liang Y, Zhang R, Zhang S, Ji G, Shi P, Yang T, Liu F, Feng J, Li C, Guo D, Chen M (2017) Association of ACYP2 and TSPYL6 genetic polymorphisms with risk of ischemic stroke in Han Chinese population. Mol Neurobiol 54:5988–5995
Liu C, Yang J, Zhang C, Liu M, Geng X, Ji X, Du H, Zhao H (2018) Analysis of long non-coding RNA expression profiles following focal cerebral ischemia in mice. Neurosci Lett 665:123–129
Lucas A, Yaron JR, Zhang L, Ambadapadi S (2018) Overview of Serpins and Their Roles in Biological Systems. Methods Mol Biol 1826:1–7
Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, Rutten-Jacobs L, Giese AK, van der Laan SW, Gretarsdottir S, Anderson CD, Chong M, Adams HHH, Ago T, Almgren P, Amouyel P, Ay H, Bartz TM, Benavente OR, Bevan S, Boncoraglio GB, Brown RD, Jr., Butterworth AS, Carrera C, Carty CL, Chasman DI, Chen WM, Cole JW, Correa A, Cotlarciuc I, Cruchaga C, Danesh J, de Bakker PIW, DeStefano AL, den Hoed M, Duan Q, Engelter ST, Falcone GJ, Gottesman RF, Grewal RP, Gudnason V, Gustafsson S, Haessler J, Harris TB, Hassan A, Havulinna AS, Heckbert SR, Holliday EG, Howard G, Hsu FC, Hyacinth HI, Ikram MA, Ingelsson E, Irvin MR, Jian X, Jimenez-Conde J, Johnson JA, Jukema JW, Kanai M, Keene KL, Kissela BM, Kleindorfer DO, Kooperberg C, Kubo M, Lange LA, Langefeld CD, Langenberg C, Launer LJ, Lee JM, Lemmens R, Leys D, Lewis CM, Lin WY, Lindgren AG, Lorentzen E, Magnusson PK, Maguire J, Manichaikul A, McArdle PF, Meschia JF, Mitchell BD, Mosley TH, Nalls MA, Ninomiya T, O’Donnell MJ, Psaty BM, Pulit SL, Rannikmae K, Reiner AP, Rexrode KM, Rice K, Rich SS, Ridker PM, Rost NS, Rothwell PM, Rotter JI, Rundek T, Sacco RL, Sakaue S, Sale MM, Salomaa V, Sapkota BR, Schmidt R, Schmidt CO, Schminke U, Sharma P, Slowik A, Sudlow CLM, Tanislav C, Tatlisumak T, Taylor KD, Thijs VNS, Thorleifsson G, Thorsteinsdottir U, Tiedt S, Trompet S, Tzourio C, van Duijn CM, Walters M, Wareham NJ, Wassertheil-Smoller S, Wilson JG, Wiggins KL, Yang Q, Yusuf S, Consortium AF, Cohorts for H, Aging Research in Genomic Epidemiology C, International Genomics of Blood Pressure C, Consortium I, Starnet, Bis JC, Pastinen T, Ruusalepp A, Schadt EE, Koplev S, Bjorkegren JLM, Codoni V, Civelek M, Smith NL, Tregouet DA, Christophersen IE, Roselli C, Lubitz SA, Ellinor PT, Tai ES, Kooner JS, Kato N, He J, van der Harst P, Elliott P, Chambers JC, Takeuchi F, Johnson AD, BioBank Japan Cooperative Hospital G, Consortium C, Consortium E-C, Consortium EP-I, International Stroke Genetics C, Consortium M, Neurology Working Group of the CC, Network NSG, Study UKYLD, Consortium M, Sanghera DK, Melander O, Jern C, Strbian D, Fernandez-Cadenas I, Longstreth WT, Jr., Rolfs A, Hata J, Woo D, Rosand J, Pare G, Hopewell JC, Saleheen D, Stefansson K, Worrall BB, Kittner SJ, Seshadri S, Fornage M, Markus HS, Howson JMM, Kamatani Y, Debette S, Dichgans M (2018) Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet 50:524–537
Mangan MS, Melo-Silva CR, Luu J, Bird CH, Koskinen A, Rizzitelli A, Prakash M, Scarff KL, Mullbacher A, Regner M, Bird PI (2017) A pro-survival role for the intracellular granzyme B inhibitor Serpinb9 in natural killer cells during poxvirus infection. Immunol Cell Biol 95:884–894
Meadows KL (2018) Ischemic stroke and select adipose-derived and sex hormones: a review. Hormones 17:167–182
Mehta SL, Kim T, Vemuganti R (2015) Long noncoding RNA FosDT promotes ischemic brain injury by interacting with REST-associated chromatin-modifying proteins. The Journal of neuroscience: the official journal of the Society for Neuroscience 35:16443–16449
Meschia JF, Nalls M, Matarin M, Brott TG, Brown RD, Jr., Hardy J, Kissela B, Rich SS, Singleton A, Hernandez D, Ferrucci L, Pearce K, Keller M, Worrall BB, Siblings With Ischemic Stroke Study I (2011) Siblings with ischemic stroke study: results of a genome-wide scan for stroke loci. Stroke 42:2726–2732
Mukhopadhyay S, Johnson TA, Sarkar R, Antalis TM (2018) Serpins in venous thrombosis and venous thrombus resolution. Methods Mol Biol 1826:197–211
Neurology Working Group of the Cohorts for H, Aging Research in Genomic Epidemiology Consortium tSGN, the International Stroke Genetics C (2016) Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies. The Lancet Neurology 15:695–707
Pan JX (2017) LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway. Eur Rev Med Pharmacol Sci 21:322–328
Petrone AB, O’Connell GC, Regier MD, Chantler PD, Simpkins JW, Barr TL (2016) The role of arginase 1 in post-stroke immunosuppression and ischemic stroke severity. Transl Stroke Res 7:103–110
Poorthuis MH, Algra AM, Algra A, Kappelle LJ, Klijn CJ (2017) Female- and male-specific risk factors for stroke: a systematic review and meta-analysis. JAMA Neurol 74:75–81
Praetner M, Zuchtriegel G, Holzer M, Uhl B, Schaubacher J, Mittmann L, Fabritius M, Furst R, Zahler S, Funken D, Lerchenberger M, Khandoga A, Kanse S, Lauber K, Krombach F, Reichel CA (2018) Plasminogen activator inhibitor-1 promotes neutrophil infiltration and tissue injury on ischemia-reperfusion. Arterioscler Thromb Vasc Biol 38:829–842
Reyahi A, Nik AM, Ghiami M, Gritli-Linde A, Ponten F, Johansson BR, Carlsson P (2015) Foxf2 is required for brain pericyte differentiation and development and maintenance of the blood-brain barrier. Dev Cell 34:19–32
Sanad EF, Hamdy NM, El-Etriby AK, Sebak SA, El-Mesallamy HO (2017) Peripheral leucocytes and tissue gene expression of granzyme B/perforin system and serpinB9: impact on inflammation and insulin resistance in coronary atherosclerosis. Diabetes Res Clin Pract 131:132–141
Tan RY, Markus HS (2015) Monogenic causes of stroke: now and the future. J Neurol 262:2601–2616
van der Burgh R, Meeldijk J, Jongeneel L, Frenkel J, Bovenschen N, van Gijn M, Boes M (2016) Reduced serpinB9-mediated caspase-1 inhibition can contribute to autoinflammatory disease. Oncotarget 7:19265–19271
Wang J, Zhao H, Fan Z, Li G, Ma Q, Tao Z, Wang R, Feng J, Luo Y (2017) Long noncoding RNA H19 Promotes neuroinflammation in ischemic stroke by driving histone deacetylase 1-dependent M1 microglial polarization. Stroke 48:2211–2221
Wang L, Liu J, Yang Y, Peng B, Wang Y (2018) Report on stroke prevention and treatment in China 2017. Chinese Journal of Cerebrovascular Disease 15:611–617
Wang Y, Liu J, Wu H, Cai Y (2018) Combined biomarkers composed of environment and genetic factors in stroke. Biosci Trends 12:360–368
Wei YS, Xiang Y, Liao PH, Wang JL, Peng YF (2016) An rs4705342 T>C polymorphism in the promoter of miR-143/145 is associated with a decreased risk of ischemic stroke. Sci Rep 6:34620
Williams FM, Carter AM, Hysi PG, Surdulescu G, Hodgkiss D, Soranzo N, Traylor M, Bevan S, Dichgans M, Rothwell PM, Sudlow C, Farrall M, Silander K, Kaunisto M, Wagner P, Saarela O, Kuulasmaa K, Virtamo J, Salomaa V, Amouyel P, Arveiler D, Ferrieres J, Wiklund PG, Ikram MA, Hofman A, Boncoraglio GB, Parati EA, Helgadottir A, Gretarsdottir S, Thorsteinsdottir U, Thorleifsson G, Stefansson K, Seshadri S, DeStefano A, Gschwendtner A, Psaty B, Longstreth W, Mitchell BD, Cheng YC, Clarke R, Ferrario M, Bis JC, Levi C, Attia J, Holliday EG, Scott RJ, Fornage M, Sharma P, Furie KL, Rosand J, Nalls M, Meschia J, Mosely TH, Evans A, Palotie A, Markus HS, Grant PJ, Spector TD, Euro CI, Wellcome Trust Case Control C, Monica Risk GA, Monograph, MetaStroke, International Stroke Genetics C (2013) Ischemic stroke is associated with the ABO locus: the EuroCLOT study. Ann Neurol 73:16–31
Wu N, Chen X, Cai T, Wu L, Xiang Y, Zhang M, Li Y, Song Z, Zhong L (2015) Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: a systematic review and meta-analysis. Can J Cardiol 31:278–286
Wu W, Asakawa T, Yang Q, Zhao J, Lu L, Luo Y, Gong P, Han S, Li W, Namba H, Wang L (2017) Effects of neuroserpin on clinical outcomes and inflammatory markers in Chinese patients with acute ischemic stroke. Neurol Res 39:862–868
Wzorek J, Karpinski M, Wypasek E, Michalski M, Szczudlik A, Malinowski KP, Undas A (2018) Alpha-2-antiplasmin Arg407Lys polymorphism and cryptogenic ischemic cerebrovascular events: association with neurological deficit. Neurol Neurochir Pol 52:352–358
Xu X, Zhuang C, Chen L (2020) Exosomal long non-coding RNA expression from serum of patients with acute minor stroke. Neuropsychiatr Dis Treat 16:153–160
Yang J, Gu L, Guo X, Huang J, Chen Z, Huang G, Kang Y, Zhang X, Long J, Su L (2018) LncRNA ANRIL expression and ANRIL gene polymorphisms contribute to the risk of ischemic stroke in the Chinese Han population. Cell Mol Neurobiol 38:1253–1269
Yi X, Lin J, Wang C, Zhou Q (2017) CYP genetic variants, CYP metabolite levels, and neurologic deterioration in acute ischemic stroke in Chinese population. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 26:969–978
Young JL, Sukhova GK, Foster D, Kisiel W, Libby P, Schonbeck U (2000) The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J Exp Med 191:1535–1544
Zhang H, Yin Y, Zhang C, Zhang D (2019) Costs of hospitalization for stroke from two urban health insurance claims data in Guangzhou City, southern China. BMC Health Serv Res 19:671
Zhang J, Yuan L, Zhang X, Hamblin MH, Zhu T, Meng F, Li Y, Chen YE, Yin KJ (2016) Altered long non-coding RNA transcriptomic profiles in brain microvascular endothelium after cerebral ischemia. Exp Neurol 277:162–170
Zhang Y, Cheng X, Liang H, Jin Z (2018) Long non-coding RNA HOTAIR and STAT3 synergistically regulate the cervical cancer cell migration and invasion. Chem Biol Interact 286:106–110
Zhang Y, Zhang Y (2020) lncRNA ZFAS1 improves neuronal injury and inhibits inflammation, oxidative stress, and apoptosis by sponging miR-582 and upregulating NOS3 expression in cerebral ischemia/reperfusion injury. Inflammation 43:1337–1350
Zheng Z, Liu S, Wang C, Han X (2018) A functional polymorphism rs145204276 in the promoter of long noncoding RNA GAS5 is associated with an increased risk of ischemic stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 27:3535–3541
Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, Li X, Wang L, Wang L, Liu Y, Liu J, Zhang M, Qi J, Yu S, Afshin A, Gakidou E, Glenn S, Krish VS, Miller-Petrie MK, Mountjoy-Venning WC, Mullany EC, Redford SB, Liu H, Naghavi M, Hay SI, Wang L, Murray CJL, Liang X (2019) Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 394:1145–1158
Zhu M, Li N, Luo P, Jing W, Wen X, Liang C, Tu J (2018) Peripheral blood leukocyte expression of lncRNA MIAT and its diagnostic and prognostic value in ischemic stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 27:326–337
Zhu R, Liu X, He Z (2018) Long non-coding RNA H19 and MALAT1 gene variants in patients with ischemic stroke in a northern Chinese Han population. Mol Brain 11:58
Acknowledgements
The present study was funded by the National Natural Science Foundation of China (Nos. 81573756 and 81473670).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethics committee of the Guangxi University of Chinese Medicine and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Huang, J., Zhu, L., Zhao, X. et al. LncRNA SERPINB9P1 expression and polymorphisms are associated with ischemic stroke in a Chinese Han population. Neurol Sci 43, 1143–1154 (2022). https://doi.org/10.1007/s10072-021-05418-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-021-05418-5